Clinical trial

Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers

NCT04614233

Study summary

ClinicalTrials.gov

Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention RiduZone (90% OEA) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-04-06

PhasePHASE4

Conditions

Overweight and Obesityunresolved

Interventions

RiduZone (90% OEA)DIETARY_SUPPLEMENT

PlaceboDRUG

Sponsors & collaborators

Yale Universitylead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04614233 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.